MEDTRONIC PLCDL-.0001 news, videos and press releases - Page 5
For more news please use our advanced search feature.
MEDTRONIC PLCDL-.0001 - More news...
MEDTRONIC PLCDL-.0001 - More news...
- Medtronic Acquires Stimgenics, Pioneer of DTM™, a Novel Spinal Cord Stimulation Therapy
- Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference
- Medtronic Expands Surgical Synergy(SM) with FDA Clearance of the Stealth Autoguide™ System for Cranial Procedures
- Medtronic Acquires Klue
- Medtronic and ChristianaCare Collaborate to Improve Patient Outcomes and Reduce Cost of Care in Delaware
- Medtronic Announces Cash Dividend for Third Quarter of Fiscal Year 2020
- Medtronic Drug-Coated Balloon Receives U.S. FDA Approval to Treat Arteriovenous Fistula Lesions
- Medtronic Reports Second Quarter Financial Results
- Medtronic Highlights Leadership in Inclusion, Diversity, and Equity in 2019 Integrated Performance Report
- New Study Shows Promise in Treating More Patients with World’s Smallest Pacemaker
- Four-Year Data from the IN.PACT Global Study Highlight Durable Performance and Safety of IN.PACT™ Admiral™ DCB
- Medtronic to Announce Financial Results for Its Second Quarter of Fiscal Year 2020
- Medtronic Announces Shonin Approval and Launch of the Valiant Navion™ Thoracic Stent Graft System in Japan
- Medtronic Launches New Activa™ Patient Programmer for DBS Therapy
- Medtronic Receives FDA “Breakthrough Device Designation” for Developing Fully Implantable Heart Pump
- Medtronic Launches the First Artificial Intelligence System for Colonoscopy at United European Gastroenterology Week 2019
- FDA Classifies Medtronic Sherpa Delivery Catheter Field Action Initiated in March 2019 as Class I Recall
- Medtronic Receives FDA Breakthrough Device Designation for Developing Stent Graft System to Treat Thoracoabdominal Aortic Aneurysm
- Medtronic Initiates Worldwide Pivotal Study of a New Approach to Treating Dangerously Fast Heart Rhythms
- Medtronic Announces FDA Submission for InterStim™ Micro Neurostimulator and SureScan™ MRI Leads
- Medtronic Announces Early Feasibility Trial for Intrepid™ Transcatheter Mitral Valve Replacement System with Transfemoral Transseptal Approach
- Resolute Onyx™ DES Meets Primary Endpoint in First-Ever Clinical Study Comparing Drug-Eluting Stents in High-Bleeding Risk (HBR) Patients with One-Month DAPT
- Medtronic Announces New Clinical Trial to Study Infuse Bone Graft in TLIF Spine Procedures
- Medtronic Surgical Synergy(SM) is Advanced with Range of New Procedural Solutions Unveiled at NASS 2019
- Medtronic Announces FDA Approval and U.S. Launch of Next-Generation Evolut™ PRO+ TAVR System for Treatment of Symptomatic Severe Aortic Stenosis Patients
- Medtronic Introduces Envision™ Pro Continuous Glucose Monitoring (CGM) System in Europe
- Medtronic Announces Robotic-Assisted Surgery Investor Update
- National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)
- Medtronic and Novo Nordisk Enter Agreement to Provide Integrated Digital Solutions for People with Diabetes
- Medtronic Named a Leading Sustainability Company
